Page last updated: 2024-09-03

cucurbitacins and Neoplasms

cucurbitacins has been researched along with Neoplasms in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's5 (55.56)24.3611
2020's4 (44.44)2.80

Authors

AuthorsStudies
Aggarwal, D; Capinpin, SM; Chauhan, A; Dhama, K; Kumar, AP; Kumar, M; Lee, EHC; Ramniwas, S; Ranjan, A; Rath, P; Sak, K; Tuli, HS; Yap, KC1
Haque, S; Kaur, S; Kumar, A; Parashar, G; Parashar, NC; Ramniwas, S; Rani, I; Sharma, B; Sharma, U; Tuli, HS1
Gao, C; Li, H; Li, Y; Sun, C; Yao, Y; Zhuang, J1
Farooqi, AA; Lin, X1
Ali, M; Green, IR; Hussain, H; Irshad, M; Khattak, KF; Saleem, M1
Arumuggam, N; Bhowmick, NA; Rupasinghe, HP1
Cai, Y; Chen, M; Fang, X; He, C; Li, P; Wang, Y; Xiao, F1
Iwanski, GB; Lee, DH; Thoennissen, NH1
Bao, J; Chen, X; Ding, Q; Guo, J; Huang, M; Lu, J; Wang, Y1

Reviews

9 review(s) available for cucurbitacins and Neoplasms

ArticleYear
Cucurbitacins as Potent Chemo-Preventive Agents: Mechanistic Insight and Recent Trends.
    Biomolecules, 2022, 12-27, Volume: 13, Issue:1

    Topics: Antineoplastic Agents; Apoptosis; Cucurbitacins; Humans; Neoplasms; Signal Transduction; Triterpenes

2022
Apoptotic and antimetastatic effect of cucurbitacins in cancer: recent trends and advancement.
    Naunyn-Schmiedeberg's archives of pharmacology, 2023, Volume: 396, Issue:9

    Topics: Apoptosis; Cell Proliferation; Cucurbitacins; Humans; Neoplasms; Phosphatidylinositol 3-Kinases; Triterpenes

2023
Potential of cucurbitacin as an anticancer drug.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2023, Volume: 168

    Topics: Antineoplastic Agents; Cell Cycle Checkpoints; Cell Proliferation; Cucurbitacins; Humans; Neoplasms; Triterpenes

2023
Cucurbitacin mediated regulation of deregulated oncogenic signaling cascades and non-coding RNAs in different cancers: Spotlight on JAK/STAT, Wnt/β-catenin, mTOR, TRAIL-mediated pathways.
    Seminars in cancer biology, 2021, Volume: 73

    Topics: Animals; Cucurbitacins; Humans; Janus Kinases; Neoplasms; Phytochemicals; RNA, Untranslated; Signal Transduction; STAT Transcription Factors; TNF-Related Apoptosis-Inducing Ligand; TOR Serine-Threonine Kinases; Wnt Signaling Pathway

2021
Cucurbitacins as Anticancer Agents: A Patent Review.
    Recent patents on anti-cancer drug discovery, 2019, Volume: 14, Issue:2

    Topics: Animals; Antineoplastic Agents, Phytogenic; Cucurbitacins; Drug Design; Humans; Neoplasms; Patents as Topic; Structure-Activity Relationship; Triterpenes

2019
A Review: Phytochemicals Targeting JAK/STAT Signaling and IDO Expression in Cancer.
    Phytotherapy research : PTR, 2015, Volume: 29, Issue:6

    Topics: Animals; Catechin; Cell Proliferation; Cucurbitacins; Curcumin; Disease Models, Animal; Humans; Indoleamine-Pyrrole 2,3,-Dioxygenase; Janus Kinases; Neoplasms; Phytochemicals; Resveratrol; Signal Transduction; STAT Transcription Factors; Stilbenes

2015
Cucurbitacins: A Systematic Review of the Phytochemistry and Anticancer Activity.
    The American journal of Chinese medicine, 2015, Volume: 43, Issue:7

    Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Transformation, Neoplastic; Cucurbitacins; Docetaxel; Drug Therapy, Combination; Humans; Methotrexate; Molecular Conformation; Neoplasm Invasiveness; Neoplasms; Phytotherapy; Signal Transduction; Structure-Activity Relationship; Taxoids

2015
Cucurbitacin: ancient compound shedding new light on cancer treatment.
    TheScientificWorldJournal, 2010, Mar-05, Volume: 10

    Topics: Antineoplastic Agents; Cucurbitacins; Drug Screening Assays, Antitumor; Humans; MAP Kinase Signaling System; Neoplasms; Transcription Factors

2010
Biological activities and potential molecular targets of cucurbitacins: a focus on cancer.
    Anti-cancer drugs, 2012, Volume: 23, Issue:8

    Topics: Animals; Antineoplastic Agents, Phytogenic; Cucurbitacins; Drug Design; Humans; Molecular Targeted Therapy; Neoplasms

2012